For Steph Lauwereys and her husband Eric, the past year has been a whirlwind of medical challenges, emotional resilience, and community support. What began nearly three years ago with a diagnosis of ...

On Monday, the Warradale teen flew more than 16,000km to Jacksonville, Florida, where he will spend 12 weeks undergoing proton therapy for clival chordoma – a rare malignant tumour. The federal ...

Tracy Bacenas is all too familiar with storytelling. She’s been an editor for widely popular TV reality series such as Survivor, Amazing Race and The Bachelor, where she’s kept viewers on the edge of ...

Inhibrx Biosciences, Inc. ((INBX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...

The last time I spoke about Inhibrx Biosciences, Inc. (INBX), it was in a Seeking Alpha article entitled "Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi." In that article, I noted ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...

SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare ...

Chondrosarcomas are a malignant form of bone cancer that is composed of cartilage-forming tumor cells. Sellar chondrosarcomas, which occur in the sellar region at the base of the skull, are a very ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...